查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
藥用明膠市場：2019-2029年全球市場規模、佔有率、趨勢分析、機遇和預測報告
市場調查報告書
商品編碼
1310390

藥用明膠市場：2019-2029年全球市場規模、佔有率、趨勢分析、機遇和預測報告

Pharmaceutical Gelatin Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Source ; By Function ; By Type ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2029年全球藥用明膠市場規模將達到18億美元

由於對控制的日益關注，例如慢性疾病的增加、明膠的有利特性以及先進的藥用明膠的推出，全球藥用明膠市場正在蓬勃發展。

領先的戰略諮詢和市場研究公司 BlueWeave Consulting 最近的一項研究估計，2022 年全球藥用明膠市場價值將達到 12.2 億美元。 BlueWeave預測，在2023-2029年預測期內，全球藥用明膠市場規模將以5.48%的年複合成長率成長，2029年達到17.6億美元。全球藥用明膠市場的主要成長促進因素包括對藥用明膠的需求不斷成長、慢性病新興市場不斷成長、全球人口迅速老齡化以及明膠奈米粒子在藥物和疫苗中的利用。明膠在化妝品用途、明膠特定功能、生物醫學用途（如傷口敷料和癒合、基因治療、組織工程、植入物和骨替代品）中的廣泛使用進一步推動了市場的擴張。此外，在預測期內，明膠用於藥物輸送的用途的增加預計也將支持藥用明膠市場的擴張。然而，向非明膠膠囊的轉變預計將阻礙整個市場的成長。

本報告的詳細分析提供了有關全球藥用明膠市場的成長潛力、未來趨勢和統計數據的資訊。我們還關注推動市場總規模預測的因素。該報告致力於提供全球藥用明膠市場的最新技術趨勢以及行業見解，幫助決策者做出明智的戰略決策。它還分析了市場的成長促進因素、挑戰和競爭動態。

目錄

第1章 研究框架

第2章 執行摘要

第3章 全球藥用明膠市場洞察

  • 行業價值鏈分析
  • DROC分析
    • 成長動力
      • 明膠的優點和特性
      • 推出先進藥用明膠
    • 抑制因素
      • 過渡到非明膠膠囊
    • 機會
      • 新興國家對藥用明膠的需求
    • 任務
      • 明膠成本高
  • 技術進步/最新發展
  • 監管框架
  • 波特五力分析

第4章 全球藥用明膠市場概況

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按來源
      • 豬
      • 牛皮
      • 牛骨
      • 海洋
      • 家禽
    • 按功能分類
      • 穩定劑
      • 增稠劑
      • 稠化劑
      • 其他
    • 按類型
      • A型
      • B型
    • 按用途
      • 硬膠囊
      • 軟膠囊
      • 錠劑
      • 可吸收止血劑
      • 其他
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第5章 北美藥用明膠市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按來源
    • 按功能分類
    • 按類型
    • 按用途
    • 按國家/地區
      • 美國
      • 加拿大

第6章 歐洲藥用明膠市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按來源
    • 按功能分類
    • 按類型
    • 按用途
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第7章 亞太藥用明膠市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按來源
    • 按功能分類
    • 按類型
    • 按用途
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳大利亞和紐西蘭
      • 印度尼西亞
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區其他國家

第8章 拉丁美洲藥用明膠市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按來源
    • 按功能分類
    • 按類型
    • 按用途
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 拉丁美洲其他地區

第9章 中東和非洲藥用明膠市場

  • 2019-2029年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按來源
    • 按功能分類
    • 按類型
    • 按用途
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • MEA 的其餘部分

第10章 競爭格局

  • 關鍵人物及其來源清單
  • 2022年全球藥用明膠企業市場佔有率分析
  • 通過管理參數進行競爭基準測試
  • 主要戰略發展（合併、收購、合作夥伴關係等）

第11章COVID-19 對全球藥用明膠市場的影響

第12章公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人才、主要競爭、聯繫地址、戰略展望、SWOT分析）

  • Gelita AG
  • Trobas Pharmaceutical gelatine BV
  • Rousselot
  • Weishardt
  • Sterling Gelatin
  • Catalent, Inc
  • Nitta Pharmaceutical gelatin India Limited
  • Aspire Pharmaceuticals
  • Junca Gelatines
  • Gelco International
  • Norland Products Inc
  • Lapi Gelatine Spa
  • Trobus Gelatine BV
  • Other Prominent Players

第13章關鍵戰略建議

第14章調查方法

簡介目錄
Product Code: BWC23546

Global Pharmaceutical Gelatin Market Size Set to Touch USD 1.8 Billion by 2029.

Global pharmaceutical gelatin market is flourishing because of the growing focus on the management of increasing prevalence of chronic illnesses, favorable properties of gelatin, and the launch of advanced pharma gelatin.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global pharmaceutical gelatin market size at USD 1.22 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global pharmaceutical gelatin market size to grow at a CAGR of 5.48% reaching a value of USD 1.76 billion by 2029. Major growth drivers for the global pharmaceutical gelatin market include an increasing need for pharmaceutical-grade gelatin, the growing prevalence of chronic illnesses, rapidly aging world population, and the progressing developments in the utilization of gelatin nanoparticles in medications and vaccines. The expanding utilization of gelatin in cosmetic applications, its inherent functionalities, as well as its biomedical applications in wound dressing and healing, gene therapy, tissue engineering, implants, and bone substitutes, are further fueling the expansion of the market. Also, the increasing progress in utilizing gelatin for drug delivery purposes is expected to propel the market expansion of pharmaceutical gelatin during the forecast period. However, shift towards non-gelatin capsules is anticipated to hinder the overall market growth.

Global Pharmaceutical Gelatin Market - Overview:

Pharmaceutical gelatin, derived from collagen extracted from animal body parts, is a transparent, long-lasting, inherently tasteless, and odorless food product. It possesses a dry and brittle texture when dry, while being flexible and rubbery when moist. It finds extensive applications as a gelling agent in the pharmaceutical industry for drugs, vitamins, medicines, photographic films & documents, as well as cosmetics. The production process for hard gelatin capsules involves immersing them in a warm bath of gelatin solution, followed by drying, pinning, and cutting of cap and body components, which are then assembled for distribution. These capsules are typically filled with dry forms of pharmaceutical or supplemental products by pharmaceutical or health companies. On the other hand, the manufacturing of soft gelatin capsules begins with the creation of two sheets of soft gelatin, each passing through a die to achieve the desired capsule size and shape. During capsule production, the medication or health supplements are filled with a liquid dose simultaneously. The dose and layer can serve as binding agents to eliminate unpleasant taste and odor, while also facilitating product identification. The specific gelatin melt characteristic also plays a significant role in the controlled and rapid release of medicines. Gelatin is also utilized in the production of suppositories.

Impact of COVID-19 on Global Pharmaceutical Gelatin Market:

COVID-19 pandemic adversely affected the global pharmaceutical gelatin market. Initially, the market experienced disruptions in supply chains and production capacity limitations due to lockdowns, travel restrictions, and disruptions in transportation and logistics. These challenges led to difficulties in procuring raw materials for gelatin production and resulted in limited availability of pharmaceutical gelatin. Also, the pharmaceutical industry as a whole faced delays in clinical trials, regulatory approvals, and new product launches, which indirectly affected the demand for gelatin. However, as the pandemic situation improved and healthcare systems stabilized, the global pharmaceutical gelatin market started showing positive signs of recovery. There was a renewed focus on R&D, including the development of vaccines and therapeutics, which increased the demand for gelatin. Pharmaceutical companies began diversifying their supplier base and exploring alternative sourcing options to enhance supply chain resilience. The market witnessed a gradual rebound in demand for gelatin as healthcare needs resumed, and the industry adapted to the new normal.

Global Pharmaceutical Gelatin Market - By Function:

Based on function, the global pharmaceutical gelatin market is divided into Stabilizing Agent, Thickening Agent, and Gelling Agent segments. The stabilizing agent segment holds the highest share in the global pharmaceutical gelatin market. Stabilizing agents are essential components in the production of gelatin-based pharmaceutical formulations, as they help maintain the stability, integrity, and shelf life of the products. These agents prevent gelatin from undergoing degradation, aggregation, or changes in physical and chemical properties. They play a crucial role in ensuring the quality and efficacy of pharmaceutical gelatin in various applications, including capsules, coatings, and drug delivery systems. The high demand for stabilizing agents is driven by the need for reliable and consistent gelatin formulations that meet regulatory requirements and deliver optimal performance in pharmaceutical applications.

Competitive Landscape:

Major players operating in the global pharmaceutical gelatin market include: Gelita AG, Trobas Pharmaceutical gelatine B.V, Rousselot, Weishardt, Sterling Gelatin, Catalent, Inc, Nitta Pharmaceutical gelatin India Limited, Aspire Pharmaceuticals, Junca Gelatines, Gelco International, Norland Products Inc, Lapi Gelatine S.p.a, and Trobus Gelatine B.V. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Pharmaceutical Gelatin Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Pharmaceutical Gelatin Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Source Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Pharmaceutical Gelatin Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Advantages & properties of Gelatin
      • 3.2.1.2. Launch of Advanced Pharma Gelatin
    • 3.2.2. Restraints
      • 3.2.2.1. Shift Towards Non-Gelatin Capsules
    • 3.2.3. Opportunities
      • 3.2.3.1. Demand of Pharma Gelatin in Developing Countries
    • 3.2.4. Challenges
      • 3.2.4.1. High Cost of Gelatins
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Pharmaceutical Gelatin Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Source
      • 4.2.1.1. Porcine
      • 4.2.1.2. Bovine Skin
      • 4.2.1.3. Bovine Bone
      • 4.2.1.4. Marine
      • 4.2.1.5. Poultry
    • 4.2.2. By Function
      • 4.2.2.1. Stabilizing Agent
      • 4.2.2.2. Thickening Agent
      • 4.2.2.3. Gelling Agent
      • 4.2.2.4. Others
    • 4.2.3. By Type
      • 4.2.3.1. Type A
      • 4.2.3.2. Type B
    • 4.2.4. By Application
      • 4.2.4.1. Hard Capsules
      • 4.2.4.2. Softgel Capsules
      • 4.2.4.3. Tablets
      • 4.2.4.4. Absorbable Hemostats
      • 4.2.4.5. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America (LATAM)
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Pharmaceutical Gelatin Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source
    • 5.2.2. By Function
    • 5.2.3. By Type
    • 5.2.4. By Application
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Source
      • 5.2.5.1.2. By Function
      • 5.2.5.1.3. By Type
      • 5.2.5.1.4. By Application
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Source
      • 5.2.5.2.2. By Function
      • 5.2.5.2.3. By Type
      • 5.2.5.2.4. By Application

6. Europe Pharmaceutical Gelatin Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By Function
    • 6.2.3. By Type
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Source
      • 6.2.5.1.2. By Function
      • 6.2.5.1.3. By Type
      • 6.2.5.1.4. By Application
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Source
      • 6.2.5.2.2. By Function
      • 6.2.5.2.3. By Type
      • 6.2.5.2.4. By Application
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Source
      • 6.2.5.3.2. By Function
      • 6.2.5.3.3. By Type
      • 6.2.5.3.4. By Application
      • 6.2.5.4. France
      • 6.2.5.4.1. By Source
      • 6.2.5.4.2. By Function
      • 6.2.5.4.3. By Type
      • 6.2.5.4.4. By Application
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Source
      • 6.2.5.5.2. By Function
      • 6.2.5.5.3. By Type
      • 6.2.5.5.4. By Application
      • 6.2.5.6. Belgium
      • 6.2.5.6.1. By Source
      • 6.2.5.6.2. By Function
      • 6.2.5.6.3. By Type
      • 6.2.5.6.4. By Application
      • 6.2.5.7. Russia
      • 6.2.5.7.1. By Source
      • 6.2.5.7.2. By Function
      • 6.2.5.7.3. By Type
      • 6.2.5.7.4. By Application
      • 6.2.5.8. The Netherlands
      • 6.2.5.8.1. By Source
      • 6.2.5.8.2. By Function
      • 6.2.5.8.3. By Type
      • 6.2.5.8.4. By Application
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Source
      • 6.2.5.9.2. By Function
      • 6.2.5.9.3. By Type
      • 6.2.5.9.4. By Application

7. Asia-Pacific Pharmaceutical Gelatin Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By Function
    • 7.2.3. By Type
    • 7.2.4. By Application
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Source
      • 7.2.5.1.2. By Function
      • 7.2.5.1.3. By Type
      • 7.2.5.1.4. By Application
      • 7.2.5.2. India
      • 7.2.5.2.1. By Source
      • 7.2.5.2.2. By Function
      • 7.2.5.2.3. By Type
      • 7.2.5.2.4. By Application
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Source
      • 7.2.5.3.2. By Function
      • 7.2.5.3.3. By Type
      • 7.2.5.3.4. By Application
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Source
      • 7.2.5.4.2. By Function
      • 7.2.5.4.3. By Type
      • 7.2.5.4.4. By Application
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Source
      • 7.2.5.5.2. By Function
      • 7.2.5.5.3. By Type
      • 7.2.5.5.4. By Application
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Source
      • 7.2.5.6.2. By Function
      • 7.2.5.6.3. By Type
      • 7.2.5.6.4. By Application
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Source
      • 7.2.5.7.2. By Function
      • 7.2.5.7.3. By Type
      • 7.2.5.7.4. By Application
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Source
      • 7.2.5.8.2. By Function
      • 7.2.5.8.3. By Type
      • 7.2.5.8.4. By Application
      • 7.2.5.9. Vietnam
      • 7.2.5.9.1. By Source
      • 7.2.5.9.2. By Function
      • 7.2.5.9.3. By Type
      • 7.2.5.9.4. By Application
      • 7.2.5.10. Rest of APAC
      • 7.2.5.10.1. By Source
      • 7.2.5.10.2. By Function
      • 7.2.5.10.3. By Type
      • 7.2.5.10.4. By Application

8. Latin America Pharmaceutical Gelatin Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By Function
    • 8.2.3. By Type
    • 8.2.4. By Application
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Source
      • 8.2.5.1.2. By Function
      • 8.2.5.1.3. By Type
      • 8.2.5.1.4. By Application
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Source
      • 8.2.5.2.2. By Function
      • 8.2.5.2.3. By Type
      • 8.2.5.2.4. By Application
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Source
      • 8.2.5.3.2. By Function
      • 8.2.5.3.3. By Type
      • 8.2.5.3.4. By Application
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Source
      • 8.2.5.4.2. By Function
      • 8.2.5.4.3. By Type
      • 8.2.5.4.4. By Application
      • 8.2.5.5. Rest of LATAM
      • 8.2.5.5.1. By Source
      • 8.2.5.5.2. By Function
      • 8.2.5.5.3. By Type
      • 8.2.5.5.4. By Application

9. Middle East & Africa Pharmaceutical Gelatin Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By Function
    • 9.2.3. By Type
    • 9.2.4. By Application
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Source
      • 9.2.5.1.2. By Function
      • 9.2.5.1.3. By Type
      • 9.2.5.1.4. By Application
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Source
      • 9.2.5.2.2. By Function
      • 9.2.5.2.3. By Type
      • 9.2.5.2.4. By Application
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Source
      • 9.2.5.3.2. By Function
      • 9.2.5.3.3. By Type
      • 9.2.5.3.4. By Application
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Source
      • 9.2.5.4.2. By Function
      • 9.2.5.4.3. By Type
      • 9.2.5.4.4. By Application
      • 9.2.5.5. South Africa
      • 9.2.5.5.1. By Source
      • 9.2.5.5.2. By Function
      • 9.2.5.5.3. By Type
      • 9.2.5.5.4. By Application
      • 9.2.5.6. Nigeria
      • 9.2.5.6.1. By Source
      • 9.2.5.6.2. By Function
      • 9.2.5.6.3. By Type
      • 9.2.5.6.4. By Application
      • 9.2.5.7. Algeria
      • 9.2.5.7.1. By Source
      • 9.2.5.7.2. By Function
      • 9.2.5.7.3. By Type
      • 9.2.5.7.4. By Application
      • 9.2.5.8. Rest of MEA
      • 9.2.5.8.1. By Source
      • 9.2.5.8.2. By Function
      • 9.2.5.8.3. By Type
      • 9.2.5.8.4. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Sources
  • 10.2. Global Pharmaceutical Gelatin Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Pharmaceutical Gelatin Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Gelita AG
  • 12.2. Trobas Pharmaceutical gelatine B.V
  • 12.3. Rousselot
  • 12.4. Weishardt
  • 12.5. Sterling Gelatin
  • 12.6. Catalent, Inc
  • 12.7. Nitta Pharmaceutical gelatin India Limited
  • 12.8. Aspire Pharmaceuticals
  • 12.9. Junca Gelatines
  • 12.10. Gelco International
  • 12.11. Norland Products Inc
  • 12.12. Lapi Gelatine S.p.a
  • 12.13. Trobus Gelatine B.V.
  • 12.14. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations